Olpasiran Shows Prolonged Lipoprotein(a) Reduction: Nearly 50% Drop Maintained for Up to Year After Treatment, Study Medha Baranwal9 Sept 2024 9:48 AM ISTUSA: In a recent follow-up study of the OCEAN(a)-DOSE clinical trial, new data has revealed the extended benefits of Olpasiran, a promising siRNA...
Early Adult LDL-C and Non-HDL-C Levels Strongly Predict Later ASCVD Risk, suggests study Dr Riya Dave6 Sept 2024 8:30 AM ISTResearchers found that a single measurement of low-density lipoprotein cholesterol (LDL-C) or non-high-density lipoprotein cholesterol (non-HDL-C), if...
High Serum Lp(a) Levels Linked to Increased ASCVD Risk in Hemodialysis Patients, finds study Dr Riya Dave9 Aug 2024 8:15 PM ISTIn a study, researchers found that elevated serum lipoprotein(a) (Lp(a)) was associated with an increased risk of atherosclerotic cardiovascular...
PAD Patients Less Likely to Receive Statins, Despite Increased Cardiac Event Risk: Study Nidhi Srivastava6 Aug 2024 7:30 PM ISTIndia: A retrospective study published in the Journal of the Association of Physicians of India revealed that patients with Peripheral Arterial...
JAMA: No sex-specific differences observed in aspirin for the secondary prevention of ASCVD Jacinthlyn Sylvia17 July 2024 9:00 AM ISTA new analysis from the ADAPTABLE clinical trial unveiled no significant difference observed in safety and effectiveness between two aspirin dosages...
Evaluating the Benefits of Aspirin in Lowering ASCVD Mortality for Elevated Lp(a) Individuals Dr. Prem Aggarwal4 July 2024 12:22 PM ISTAtherosclerotic cardiovascular disease (ASCVD) among young adults is a major public health challenge with a global prevalence of 7% to 30%. (1) Due to...
Cardiovascular biomarkers strongly associated with fatal and nonfatal CV events and mortality: JAMA Dr Riya Dave16 May 2024 9:00 AM ISTResearchers in a recent study have sought to enhance risk prediction for atherosclerotic cardiovascular disease (ASCVD) by evaluating the prognostic...
High Lipoprotein(a) Levels Increase Risk of Heart Disease in Diverse Population, finds study Jacinthlyn Sylvia25 April 2024 10:00 AM ISTA recent study published in the Journal of the American College of Cardiology highlighted the increased risk of heart disease associated with higher...
Zerlasiran may prevent heart disease by lowering lipoprotein(a) concentrations: JAMA Jacinthlyn Sylvia13 April 2024 9:45 AM ISTA new study revealed that Zerlasiran is not just safe and tolerable but also effective in substantially reducing the levels of lipoprotein(a) [Lp(a)]...
Zerlasiran shows beneficial outcomes for cardiovascular disease reveals phase 2 study Jacinthlyn Sylvia23 March 2024 8:00 AM ISTResearchers have announced a promising 36-week topline data from its phase 2 ALPACAR-360 study which evaluating the efficacy of zerlasiran in patients...
Breast arterial calcification on mammography could identify women at high risk of CVD in future: Study Medha Baranwal21 March 2024 2:15 AM ISTUSA: Breast arterial calcifications (BAC) on a screening mammogram may identify women at potentially increased risk of future cardiovascular disease...
Left Main Coronary Artery Calcium and Diabetes Confer Very-High-Risk Equivalence in CAC more than 1,000: Study Medha Baranwal6 March 2024 12:15 AM ISTUSA: Among asymptomatic patients with coronary artery calcium (CAC) score > 1,000, those with severe calcium in the left main coronary artery and...
